Since sarcoidosis is a rare disease, doctors often lack the information they need in order to properly care for sarcoidosis patients. Scientists are working diligently to uncover the cause of sarcoidosis and develop a cure, but in the meantime, options for sarcoidosis...
Exciting news for the sarcoidosis community!On October 10, 2019, Boehringer Ingelheim announced that the US Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to Ofev (nintedanib), which is a new drug that is believed to slow the progression...
2019 was a big year for FSR. We hosted nine patient education events in cities all across North America, bringing together sarcoidosis patients, caregivers, expert physicians, and FSR staff. Each six-hour event provided individuals affected by sarcoidosis a chance to...
Did you know you can support FSR’s mission through your Amazon purchases? Make an impact on sarcoidosis research at no extra cost to you by purchasing your favorite Amazon items through AmazonSmile! AmazonSmile is a website operated by Amazon with the same...
